Trademark Filing
Takeda Pharmaceuticals International AG
| Serial Number | 98259188 |
| Attorney Name | Karl M. Zielaznicki, Esq. |
| Attorney Docket Number | 256532000566 |
Timeline
| 2023-11-07 | Application Filed |
| 2023-11-10 | Location: NEW APPLICATION PROCESSING |
| 2023-11-10 | Status: Live/Pending |
| 2023-11-10 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Takeda Pharmaceuticals International AG |
| Entity Statement | aktiengesellschaft |
| Address | Thurgauerstrasse 130 Glattpark-Opfikon CH 8152 |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260102 | Circles, plain single line; Plain single line circles |
| 260103 | Circles, incomplete (more than semi |
| 260115 | Circles, exactly three circles; Three circles |
| 260121 | Circles that are totally or partially shaded. |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| DM0000 | The mark consists of a solid orange circle surrounded by a broken yellow circle design, which is interrupted by a green circle with an open center on the top left side. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED | 2023-11-10 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-12-06 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2023-12-07 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2024-03-20 | 4 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2024-03-24 | 5 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2024-03-24 | 6 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2024-03-24 | 7 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2024-03-24 | 8 XAEC I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2024-03-27 | 9 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2024-03-27 | 10 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2024-03-27 | 11 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2024-03-27 | 12 XAEC I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2024-03-27 | 13 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2024-03-27 | 14 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2024-03-27 | 15 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2024-03-29 | 16 ERSI I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 